“…Visfatin, also known as NAMPT, is synthesized and secreted by tumor myeloid cells, promoting angiogenesis by targeting endothelial cells [ 39 ]. In breast cancer, NAMPT has been shown to facilitate EndMT [ 40 ]. TGFb signaling, a critical inducer of tumor EndMT [ 41 ], has been proven to trigger EndMT in various cancers, including melanoma, esophageal, colon, and lung cancers [ [42] , [43] , [44] , [45] ].…”